Citigroup’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.6K | Sell |
22,796
-62,284
| -73% | -$231K | ﹤0.01% | 3766 |
|
|
2025
Q1 | $275K | Sell |
85,080
-8,541
| -9% | -$27.6K | ﹤0.01% | 3253 |
|
|
2024
Q4 | $521K | Buy |
93,621
+3,219
| +4% | +$17.9K | ﹤0.01% | 2991 |
|
|
2024
Q3 | $977K | Buy |
90,402
+7,592
| +9% | +$82.1K | ﹤0.01% | 2577 |
|
|
2024
Q2 | $1.74M | Sell |
82,810
-70,474
| -46% | -$1.48M | ﹤0.01% | 1854 |
|
|
2024
Q1 | $4.88M | Buy |
153,284
+111,976
| +271% | +$3.57M | ﹤0.01% | 1254 |
|
|
2023
Q4 | $837K | Sell |
41,308
-13,391
| -24% | -$271K | ﹤0.01% | 2297 |
|
|
2023
Q3 | $696K | Sell |
54,699
-3,458
| -6% | -$44K | ﹤0.01% | 2166 |
|
|
2023
Q2 | $1.05M | Sell |
58,157
-53,521
| -48% | -$967K | ﹤0.01% | 2214 |
|
|
2023
Q1 | $1.92M | Buy |
111,678
+85,862
| +333% | +$1.48M | ﹤0.01% | 1563 |
|
|
2022
Q4 | $573K | Buy |
25,816
+15,922
| +161% | +$354K | ﹤0.01% | 2435 |
|
|
2022
Q3 | $80K | Sell |
9,894
-2,343
| -19% | -$18.9K | ﹤0.01% | 3492 |
|
|
2022
Q2 | $85K | Sell |
12,237
-16,358
| -57% | -$114K | ﹤0.01% | 3623 |
|
|
2022
Q1 | $432K | Sell |
28,595
-54,577
| -66% | -$825K | ﹤0.01% | 2947 |
|
|
2021
Q4 | $1.83M | Buy |
83,172
+80,369
| +2,867% | +$1.76M | ﹤0.01% | 2040 |
|
|
2021
Q3 | $76K | Buy |
2,803
+1,218
| +77% | +$33K | ﹤0.01% | 3782 |
|
|
2021
Q2 | $38K | Buy |
1,585
+217
| +16% | +$5.2K | ﹤0.01% | 4271 |
|
|
2021
Q1 | $59K | Buy |
+1,368
| New | +$59K | ﹤0.01% | 3950 |
|